Report Store
Visit Corporate Site
Sign In
Menu
Report Store
Sign in
Home
Reports
View all Reports
Reports by Sector
Aerospace and Defense
Agriculture and Forestry
Apparel
Automotive
Business and Consumer Services
Chemicals
Construction
Consumer
COVID-19
Financial Services
Foodservice
Government and Non-Profit Organisations
Industrial Goods and Machinery
Medical Devices
Mining
Oil and Gas
Packaging
Pharmaceuticals
Power
Retail
Sport
Technology
Telecommunications
Transportation, Infrastructure and Logistics
Travel and Tourism
Report Type
Company Profile
Track & Monitor
Sector Analysis
Product Insights
Analyst Opinions
Company Insights
Thematic Analysis
Case Studies
Visit Corporate Site
Search our Database
Trending:
Ukraine Crisis Briefing
Inflation
COVID-19
Sustainability
Tesla
Netflix
Vaccine
×
XORTX Therapeutics Inc
Showing all 3 results
Price - High to Low
Price - Low to High
Relevance
Date - Newest
Date - Oldest
Likelihood of Approval and Phase Transition Success Rate Model – Domvanalimab in Gastric Cancer
$
500
–
$
1,000
Select options
Likelihood of Approval and Phase Transition Success Rate Model – SIR-2446 in Alzheimer’s Disease
$
500
–
$
1,000
Select options
